glp-1 news updates New study confirms medications are safe for mental health in diabetes Thinking about GLP-1 medications for

Victoza (liraglutide), Byetta (exenatide), Bydureon (extended-release exenatide), and Trulicity (dulaglutide) are no longer eligible for weight loss coverage under many Anthem plans

How we source info

Search string: (Glucagon-Like Peptide-1 Receptor Agonist* OR GLP-1-RA* OR GLP-1-R* OR GLP-1 Receptor Agonist* OR Liraglutide OR Semaglutide OR Tirzepatide OR Exenatide OR Exendin-4) AND (Stem Cells[Mesh] OR stem cell* OR stromal cell* OR adult progenitor cell* OR hASC OR hASCs OR ASC OR ASCs OR adipose-derived stem cell* OR ADSC* OR MSC OR mesenchymal stem cell* OR mesenchymal stromal cell* OR mesenchymal progenitor cell* OR bone-marrow derived mesenchymal stem cell* OR BD-MSC* OR umbilical cord tissue derived mesenchymal stem cell* OR UC-MSC*) The date of the search was June 30th, 2025

Research is currently underway to see if taking oral weight-loss medication (such as bupropion-naltrexone) can help ease the transition off GLP-1 receptor agonists and reduce the amount of weight that's typically regained after stopping them

Every program is personalized, physician-led, and monitored closely for your success